Book a demo

Chemical intelligence powered by cypris.ai

L-Agaritine

(2S)-2-amino-5-[2-[4-(hydroxymethyl)phenyl]hydrazinyl]-5-oxopentanoic acid

FormulaC12H17N3O4
Mol. weight267.285
PubChem CID439517
InChIKeySRSPQXBFDCGXIZ-JTQLQIEISA-N
SMILESC1=CC(=CC=C1CO)NNC(=O)CC[C@@H](C(=O)O)N
103Patents
38Research papers
16Patents - last 3 years
0Papers - last 3 years

Who owns the IP

The organizations most actively patenting around this compound, ranked by referenced patent volume.

#AssigneePatents
1Versum Materials US LLC27
2Coca Cola Co4
3King Fahd University of Petroleum and Minerals3
4Honda Motor Co Ltd2
5Idemitsu Kosan Co Ltd2
6Merck Patent GmbH2
7Fuji Chemical Industries Co Ltd1
8Kureha Corp1
9Taiho Pharmaceutical Co Ltd1

Explore the full landscape

This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.

Visit Cypris

Where innovation is concentrated

Patent classifications ranked by volume reveal the technical domains with the most active filing.

#CodeAreaPatents
1C09G27
2H10P27
3H01LSemiconductor devices25
4C09KMaterials for misc. applications20
5A23VFoods, foodstuffs - indexing scheme17
6A23LFoods and beverages (general)16
7A61KMedicinal preparations15
8B24B14
9C08FPolymers from C=C unsaturated bonds12
10A01G11

AI mapped opportunity space

This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.

See Cypris in action

Where research is gaining momentum

Research themes ranked by publication activity show where scientific interest is accelerating around this compound.

#Research topicPapers
1Fungal Biology and Applications1

Who's driving the science

The most-published authors working with this compound, alongside their primary affiliations.

#AuthorAffiliationPapers
1Christian SchlatterUniversity of Zurich4
2Costas IoannidesUniversity of Surrey5
3Hiroshi AkiyamaNational Institute of Health Sciences5
4Kazunari KondoNational Institute of Health Sciences5
5Hans C. AnderssonNational Food Administration4
6J. GryUniversity of Chemistry and Technology, Prague4
7Jana HajšlováUniversity of Chemistry and Technology, Prague4
8K WaltonUniversity of Surrey4
9Ron WalkerUniversity of Surrey4
10Tamio MaitaniNational Institute of Health Sciences4

Research leaders

This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.

See Cypris in action

The literature that defines it

The most-cited papers anchoring the scientific record for this compound.

Frequently asked questions

Common questions about this compound's patent and research landscape, answered from the underlying data.

What is the molecular composition of L-Agaritine?

L-Agaritine has the molecular formula C12H17N3O4 with a molecular weight of 267.285. Its canonical IUPAC name is (2S)-2-amino-5-[2-[4-(hydroxymethyl)phenyl]hydrazinyl]-5-oxopentanoic acid, and its InChI Key is SRSPQXBFDCGXIZ-JTQLQIEISA-N.

Which organizations hold the most patents related to L-Agaritine?

The organization with the highest patent count is Versum Materials US LLC with 27 patents. Other significant patent holders include Coca Cola Co with 4 patents and King Fahd University of Petroleum and Minerals with 3 patents.

What are the primary research topics associated with L-Agaritine?

L-Agaritine has been studied in relation to several research areas including Fungal Biology and Applications, Enzyme function and inhibition, PI3K/AKT/mTOR signaling in cancer, Polyamine Metabolism and Applications, and Polysaccharides and Plant Cell Walls.

Who are the most prolific researchers publishing on L-Agaritine?

Several researchers have published 5 papers on L-Agaritine: Costas Ioannides from the University of Surrey, Hiroshi Akiyama from the National Institute of Health Sciences, and Kazunari Kondo also from the National Institute of Health Sciences. Additional active authors include Christian Schlatter from the University of Zurich and others with 4 publications each.

What is the patent activity trend for L-Agaritine?

Patent filings related to L-Agaritine show variable activity over time. The highest activity was in 2016 with 13 patents, followed by declining numbers through 2021. Recent activity has increased, with 6 patents in 2024 and 8 patents projected for 2025.

Turn any compound into a complete chemical intelligence landscape

Go beyond static compound data. Cypris resolves identities, patents, papers, and commercial signals into one AI-powered view - so your team can move from a single chemical question to a complete R&D, IP, and market landscape.

Schedule a free trial